Henry Schein Medical Inc. (Nasdaq: HSIC) will offer Atossa Genetics Inc.'s (Nasdaq: ATOS) FullCYTE Breast Aspirator to its customers. Shares of Atossa Genetics leaped 39 cents to close at $1.99 while Henry Schein Medical stock lost 57 cents to close at $140.44.
New distributor for Atossa Genetics' FullCYTE Breast Aspirator
February 26, 2015 at 17:38 PM EST
